0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Type III Collagen Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3W15534
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Type III Collagen Market Research Report 2023
BUY CHAPTERS

Global Recombinant Type III Collagen Market Research Report 2025

Code: QYRE-Auto-3W15534
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Type III Collagen Market

The global market for Recombinant Type III Collagen was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Recombinant Type III Collagen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Type III Collagen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Type III Collagen include Novus Biologicals, Evonik Industries, Advanced BioMatrix, SNIME, Shanxi Jinbo Bio-Pharmaceutical, R&D Systems, BAHE, Harbin Fuerjia Technology, Beijing Duomeikang Medical Science and Technology, Yangzhou Meirui Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Type III Collagen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Type III Collagen.
The Recombinant Type III Collagen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Type III Collagen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Type III Collagen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Type III Collagen Market Report

Report Metric Details
Report Name Recombinant Type III Collagen Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novus Biologicals, Evonik Industries, Advanced BioMatrix, SNIME, Shanxi Jinbo Bio-Pharmaceutical, R&D Systems, BAHE, Harbin Fuerjia Technology, Beijing Duomeikang Medical Science and Technology, Yangzhou Meirui Biology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Type III Collagen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Type III Collagen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Type III Collagen Market report?

Ans: The main players in the Recombinant Type III Collagen Market are Novus Biologicals, Evonik Industries, Advanced BioMatrix, SNIME, Shanxi Jinbo Bio-Pharmaceutical, R&D Systems, BAHE, Harbin Fuerjia Technology, Beijing Duomeikang Medical Science and Technology, Yangzhou Meirui Biology

What are the Application segmentation covered in the Recombinant Type III Collagen Market report?

Ans: The Applications covered in the Recombinant Type III Collagen Market report are Cartilage Repair Materials, Artificial Skin Manufacturing, Treatment Of Vaginal Disorders, Scar Prevention, Other

What are the Type segmentation covered in the Recombinant Type III Collagen Market report?

Ans: The Types covered in the Recombinant Type III Collagen Market report are Recombinant Type III Collagen Freeze-Dried Fiber, Complex Recombinant Type III Collagen Dressing, Recombinant Type III Collagen Gel, Other

Recommended Reports

Collagen Healthcare

Recombinant Proteins

Consumer Collagen

1 Recombinant Type III Collagen Market Overview
1.1 Product Definition
1.2 Recombinant Type III Collagen by Type
1.2.1 Global Recombinant Type III Collagen Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Type III Collagen Freeze-Dried Fiber
1.2.3 Complex Recombinant Type III Collagen Dressing
1.2.4 Recombinant Type III Collagen Gel
1.2.5 Other
1.3 Recombinant Type III Collagen by Application
1.3.1 Global Recombinant Type III Collagen Market Value by Application (2024 VS 2031)
1.3.2 Cartilage Repair Materials
1.3.3 Artificial Skin Manufacturing
1.3.4 Treatment Of Vaginal Disorders
1.3.5 Scar Prevention
1.3.6 Other
1.4 Global Recombinant Type III Collagen Market Size Estimates and Forecasts
1.4.1 Global Recombinant Type III Collagen Revenue 2020-2031
1.4.2 Global Recombinant Type III Collagen Sales 2020-2031
1.4.3 Global Recombinant Type III Collagen Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Type III Collagen Market Competition by Manufacturers
2.1 Global Recombinant Type III Collagen Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Type III Collagen Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Type III Collagen Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Type III Collagen, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Type III Collagen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Type III Collagen, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Type III Collagen, Date of Enter into This Industry
2.8 Global Recombinant Type III Collagen Market Competitive Situation and Trends
2.8.1 Global Recombinant Type III Collagen Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Type III Collagen Players Market Share by Revenue
2.8.3 Global Recombinant Type III Collagen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Type III Collagen Market Scenario by Region
3.1 Global Recombinant Type III Collagen Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Type III Collagen Sales by Region: 2020-2031
3.2.1 Global Recombinant Type III Collagen Sales by Region: 2020-2025
3.2.2 Global Recombinant Type III Collagen Sales by Region: 2026-2031
3.3 Global Recombinant Type III Collagen Revenue by Region: 2020-2031
3.3.1 Global Recombinant Type III Collagen Revenue by Region: 2020-2025
3.3.2 Global Recombinant Type III Collagen Revenue by Region: 2026-2031
3.4 North America Recombinant Type III Collagen Market Facts & Figures by Country
3.4.1 North America Recombinant Type III Collagen Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Type III Collagen Sales by Country (2020-2031)
3.4.3 North America Recombinant Type III Collagen Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Type III Collagen Market Facts & Figures by Country
3.5.1 Europe Recombinant Type III Collagen Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Type III Collagen Sales by Country (2020-2031)
3.5.3 Europe Recombinant Type III Collagen Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Type III Collagen Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Type III Collagen Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Type III Collagen Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Type III Collagen Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Type III Collagen Market Facts & Figures by Country
3.7.1 Latin America Recombinant Type III Collagen Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Type III Collagen Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Type III Collagen Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Type III Collagen Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Type III Collagen Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Type III Collagen Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Type III Collagen Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Type III Collagen Sales by Type (2020-2031)
4.1.1 Global Recombinant Type III Collagen Sales by Type (2020-2025)
4.1.2 Global Recombinant Type III Collagen Sales by Type (2026-2031)
4.1.3 Global Recombinant Type III Collagen Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Type III Collagen Revenue by Type (2020-2031)
4.2.1 Global Recombinant Type III Collagen Revenue by Type (2020-2025)
4.2.2 Global Recombinant Type III Collagen Revenue by Type (2026-2031)
4.2.3 Global Recombinant Type III Collagen Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Type III Collagen Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Type III Collagen Sales by Application (2020-2031)
5.1.1 Global Recombinant Type III Collagen Sales by Application (2020-2025)
5.1.2 Global Recombinant Type III Collagen Sales by Application (2026-2031)
5.1.3 Global Recombinant Type III Collagen Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Type III Collagen Revenue by Application (2020-2031)
5.2.1 Global Recombinant Type III Collagen Revenue by Application (2020-2025)
5.2.2 Global Recombinant Type III Collagen Revenue by Application (2026-2031)
5.2.3 Global Recombinant Type III Collagen Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Type III Collagen Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novus Biologicals
6.1.1 Novus Biologicals Company Information
6.1.2 Novus Biologicals Description and Business Overview
6.1.3 Novus Biologicals Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novus Biologicals Recombinant Type III Collagen Product Portfolio
6.1.5 Novus Biologicals Recent Developments/Updates
6.2 Evonik Industries
6.2.1 Evonik Industries Company Information
6.2.2 Evonik Industries Description and Business Overview
6.2.3 Evonik Industries Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Evonik Industries Recombinant Type III Collagen Product Portfolio
6.2.5 Evonik Industries Recent Developments/Updates
6.3 Advanced BioMatrix
6.3.1 Advanced BioMatrix Company Information
6.3.2 Advanced BioMatrix Description and Business Overview
6.3.3 Advanced BioMatrix Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Advanced BioMatrix Recombinant Type III Collagen Product Portfolio
6.3.5 Advanced BioMatrix Recent Developments/Updates
6.4 SNIME
6.4.1 SNIME Company Information
6.4.2 SNIME Description and Business Overview
6.4.3 SNIME Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SNIME Recombinant Type III Collagen Product Portfolio
6.4.5 SNIME Recent Developments/Updates
6.5 Shanxi Jinbo Bio-Pharmaceutical
6.5.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
6.5.2 Shanxi Jinbo Bio-Pharmaceutical Description and Business Overview
6.5.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Product Portfolio
6.5.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments/Updates
6.6 R&D Systems
6.6.1 R&D Systems Company Information
6.6.2 R&D Systems Description and Business Overview
6.6.3 R&D Systems Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.6.4 R&D Systems Recombinant Type III Collagen Product Portfolio
6.6.5 R&D Systems Recent Developments/Updates
6.7 BAHE
6.7.1 BAHE Company Information
6.7.2 BAHE Description and Business Overview
6.7.3 BAHE Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BAHE Recombinant Type III Collagen Product Portfolio
6.7.5 BAHE Recent Developments/Updates
6.8 Harbin Fuerjia Technology
6.8.1 Harbin Fuerjia Technology Company Information
6.8.2 Harbin Fuerjia Technology Description and Business Overview
6.8.3 Harbin Fuerjia Technology Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Harbin Fuerjia Technology Recombinant Type III Collagen Product Portfolio
6.8.5 Harbin Fuerjia Technology Recent Developments/Updates
6.9 Beijing Duomeikang Medical Science and Technology
6.9.1 Beijing Duomeikang Medical Science and Technology Company Information
6.9.2 Beijing Duomeikang Medical Science and Technology Description and Business Overview
6.9.3 Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Product Portfolio
6.9.5 Beijing Duomeikang Medical Science and Technology Recent Developments/Updates
6.10 Yangzhou Meirui Biology
6.10.1 Yangzhou Meirui Biology Company Information
6.10.2 Yangzhou Meirui Biology Description and Business Overview
6.10.3 Yangzhou Meirui Biology Recombinant Type III Collagen Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yangzhou Meirui Biology Recombinant Type III Collagen Product Portfolio
6.10.5 Yangzhou Meirui Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Type III Collagen Industry Chain Analysis
7.2 Recombinant Type III Collagen Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Type III Collagen Production Mode & Process Analysis
7.4 Recombinant Type III Collagen Sales and Marketing
7.4.1 Recombinant Type III Collagen Sales Channels
7.4.2 Recombinant Type III Collagen Distributors
7.5 Recombinant Type III Collagen Customer Analysis
8 Recombinant Type III Collagen Market Dynamics
8.1 Recombinant Type III Collagen Industry Trends
8.2 Recombinant Type III Collagen Market Drivers
8.3 Recombinant Type III Collagen Market Challenges
8.4 Recombinant Type III Collagen Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Recombinant Type III Collagen Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Type III Collagen Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Type III Collagen Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Type III Collagen Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Type III Collagen Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Type III Collagen Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Type III Collagen Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Type III Collagen Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Type III Collagen, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Type III Collagen, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Type III Collagen, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Type III Collagen, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Type III Collagen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Type III Collagen as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Type III Collagen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Type III Collagen Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Type III Collagen Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Type III Collagen Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Type III Collagen Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Type III Collagen Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Type III Collagen Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Type III Collagen Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Type III Collagen Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Type III Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Type III Collagen Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Type III Collagen Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Type III Collagen Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Type III Collagen Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Type III Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Type III Collagen Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Type III Collagen Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Type III Collagen Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Type III Collagen Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Type III Collagen Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Type III Collagen Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Type III Collagen Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Type III Collagen Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Type III Collagen Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Type III Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Type III Collagen Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Type III Collagen Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Type III Collagen Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Type III Collagen Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Type III Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Type III Collagen Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Type III Collagen Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Type III Collagen Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Type III Collagen Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Type III Collagen Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Type III Collagen Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Type III Collagen Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Type III Collagen Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Type III Collagen Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Type III Collagen Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Type III Collagen Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Type III Collagen Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Type III Collagen Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Type III Collagen Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Type III Collagen Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Type III Collagen Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Type III Collagen Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Type III Collagen Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Type III Collagen Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Type III Collagen Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Type III Collagen Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Type III Collagen Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Type III Collagen Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Type III Collagen Price (US$/Unit) by Application (2026-2031)
 Table 70. Novus Biologicals Company Information
 Table 71. Novus Biologicals Description and Business Overview
 Table 72. Novus Biologicals Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novus Biologicals Recombinant Type III Collagen Product
 Table 74. Novus Biologicals Recent Developments/Updates
 Table 75. Evonik Industries Company Information
 Table 76. Evonik Industries Description and Business Overview
 Table 77. Evonik Industries Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Evonik Industries Recombinant Type III Collagen Product
 Table 79. Evonik Industries Recent Developments/Updates
 Table 80. Advanced BioMatrix Company Information
 Table 81. Advanced BioMatrix Description and Business Overview
 Table 82. Advanced BioMatrix Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Advanced BioMatrix Recombinant Type III Collagen Product
 Table 84. Advanced BioMatrix Recent Developments/Updates
 Table 85. SNIME Company Information
 Table 86. SNIME Description and Business Overview
 Table 87. SNIME Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. SNIME Recombinant Type III Collagen Product
 Table 89. SNIME Recent Developments/Updates
 Table 90. Shanxi Jinbo Bio-Pharmaceutical Company Information
 Table 91. Shanxi Jinbo Bio-Pharmaceutical Description and Business Overview
 Table 92. Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Shanxi Jinbo Bio-Pharmaceutical Recombinant Type III Collagen Product
 Table 94. Shanxi Jinbo Bio-Pharmaceutical Recent Developments/Updates
 Table 95. R&D Systems Company Information
 Table 96. R&D Systems Description and Business Overview
 Table 97. R&D Systems Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. R&D Systems Recombinant Type III Collagen Product
 Table 99. R&D Systems Recent Developments/Updates
 Table 100. BAHE Company Information
 Table 101. BAHE Description and Business Overview
 Table 102. BAHE Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BAHE Recombinant Type III Collagen Product
 Table 104. BAHE Recent Developments/Updates
 Table 105. Harbin Fuerjia Technology Company Information
 Table 106. Harbin Fuerjia Technology Description and Business Overview
 Table 107. Harbin Fuerjia Technology Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Harbin Fuerjia Technology Recombinant Type III Collagen Product
 Table 109. Harbin Fuerjia Technology Recent Developments/Updates
 Table 110. Beijing Duomeikang Medical Science and Technology Company Information
 Table 111. Beijing Duomeikang Medical Science and Technology Description and Business Overview
 Table 112. Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Beijing Duomeikang Medical Science and Technology Recombinant Type III Collagen Product
 Table 114. Beijing Duomeikang Medical Science and Technology Recent Developments/Updates
 Table 115. Yangzhou Meirui Biology Company Information
 Table 116. Yangzhou Meirui Biology Description and Business Overview
 Table 117. Yangzhou Meirui Biology Recombinant Type III Collagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Yangzhou Meirui Biology Recombinant Type III Collagen Product
 Table 119. Yangzhou Meirui Biology Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Recombinant Type III Collagen Distributors List
 Table 123. Recombinant Type III Collagen Customers List
 Table 124. Recombinant Type III Collagen Market Trends
 Table 125. Recombinant Type III Collagen Market Drivers
 Table 126. Recombinant Type III Collagen Market Challenges
 Table 127. Recombinant Type III Collagen Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Type III Collagen
 Figure 2. Global Recombinant Type III Collagen Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Type III Collagen Market Share by Type: 2024 & 2031
 Figure 4. Recombinant Type III Collagen Freeze-Dried Fiber Product Picture
 Figure 5. Complex Recombinant Type III Collagen Dressing Product Picture
 Figure 6. Recombinant Type III Collagen Gel Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Recombinant Type III Collagen Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Type III Collagen Market Share by Application: 2024 & 2031
 Figure 10. Cartilage Repair Materials
 Figure 11. Artificial Skin Manufacturing
 Figure 12. Treatment Of Vaginal Disorders
 Figure 13. Scar Prevention
 Figure 14. Other
 Figure 15. Global Recombinant Type III Collagen Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Recombinant Type III Collagen Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Recombinant Type III Collagen Sales (2020-2031) & (K Units)
 Figure 18. Global Recombinant Type III Collagen Average Price (US$/Unit) & (2020-2031)
 Figure 19. Recombinant Type III Collagen Report Years Considered
 Figure 20. Recombinant Type III Collagen Sales Share by Manufacturers in 2024
 Figure 21. Global Recombinant Type III Collagen Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Recombinant Type III Collagen Players: Market Share by Revenue in Recombinant Type III Collagen in 2024
 Figure 23. Recombinant Type III Collagen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Recombinant Type III Collagen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Recombinant Type III Collagen Sales Market Share by Country (2020-2031)
 Figure 26. North America Recombinant Type III Collagen Revenue Market Share by Country (2020-2031)
 Figure 27. United States Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Recombinant Type III Collagen Sales Market Share by Country (2020-2031)
 Figure 30. Europe Recombinant Type III Collagen Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Recombinant Type III Collagen Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Recombinant Type III Collagen Revenue Market Share by Region (2020-2031)
 Figure 38. China Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Recombinant Type III Collagen Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Recombinant Type III Collagen Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Recombinant Type III Collagen Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Recombinant Type III Collagen Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Recombinant Type III Collagen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Recombinant Type III Collagen by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Recombinant Type III Collagen by Type (2020-2031)
 Figure 57. Global Recombinant Type III Collagen Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Recombinant Type III Collagen by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Recombinant Type III Collagen by Application (2020-2031)
 Figure 60. Global Recombinant Type III Collagen Price (US$/Unit) by Application (2020-2031)
 Figure 61. Recombinant Type III Collagen Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart